Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity (2024) Gege C, Hahn F, Wangen C, Häge S, Herrmann A, Uhlig N, Eberlein V, et al. Journal article Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 (2024) Huber M, Wurnig SL, Moumbock AF, Toy L, Kostenis E, Alonso Bartolomé A, Szpakowska M, et al. Journal article Development of Photoswitchable Tethered Ligands that Target the μ-Opioid Receptor (2023) Lahmy R, Hübner H, Lachmann D, Gmeiner P, König B Journal article Selectfluor-Mediated Chlorination and Fluorination of Arenes: Late-Stage Functionalization of APIs and Its Biological Effects (2023) Gradl S, Zantop V, Gmeiner P, Hübner H, Heinrich M Journal article Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and Cancer (2022) Herrmann L, Yaremenko IA, Capci Karagöz A, Struwe J, Tailor D, Dheeraj A, Hodek J, et al. Journal article Exploring Viral Interference Using Peptides: Molecular Determinants of HIV-1 Inhibition by a Peptide Derived from Human Pegivirus-1 Envelope Protein E2 (2021) Hoffmann R, Ruegamer T, Schaubaecher J, Rohrhofer A, Kirmeß P, Fiebig K, Schmidt B, Eichler J Journal article Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine-Derived Phenylazocarboxamides as Novel mu-Opioid Receptor Ligands (2020) Krüll J, Fehler S, Hofmann L, Nebel N, Maschauer S, Prante O, Gmeiner P, et al. Journal article, Original article Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors (2020) Wagner S, de Moura Gatti F, Silva DG, Ortiz Zacarias NV, Zweemer AJ, Hermann S, de Maria M, et al. Journal article Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer (2020) Fröhlich T, Mai C, Bogautdinov RP, Morozkina SN, Shavva AG, Friedrich O, Gilbert D, Tsogoeva S Journal article Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells (2019) Kuhnert R, Sarosi MB, George S, Loennecke P, Hofmann B, Steinhilber D, Steinmann S, et al. Journal article